Notably, increased heparanase levels were most often associated with reduced patient survival post-surgery, increased tumor metastasis and higher microvessel density [2,7,8], thus critically supporting the intimate involvement of heparanase in tumor progression and encouraging the development of heparanase inhibitors as anti-cancer therapeutics [9,10]. This evidence concerns the gene HPSE and cancer.